EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Mon, 18.11.2024
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.11.2024
18.11.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.11.2024
MTD
FYTD
CYTD
NAV
251.81
0.5
4.5
...
Profit of CHF 23 million
NAV up by 1.5 percent and share price up by 1.7 percent
Private as well as public portfolio companies contribute to earnings
Unfavourable currency movements impact performance by almost 5 percent
Successful first half – currency effects impact performance
HBM Healthcare Investments generated a profit of CHF 23 milli...
Profit of CHF 23 million
NAV up by 1.5 percent and share price up by 1.7 percent
Private as well as public portfolio companies contribute to earnings
Unfavourable currency movements impact performance by almost 5 percent
Successful first half – currency effects impact performance
HBM Healthcare Investments generated a profit of CHF 23 milli...
HBM Healthcare Investments AG
/ Key word(s): IPO
HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering
14.10.2024 / 06:30 CET/CEST
Upstream Bio (Nasdaq: UPB), a previously private company in the HBM Healthcare Investments portfolio, got off to a successful start on the stock m...
HBM Healthcare Investments achieved a positive performance in the first half of the 2024/2025 financial year. The net asset value per share (NAV) increased by 1.5 per cent to CHF 244.34. The share price rose by 1.7 per cent to CHF 189.40.
Based on the reported NAV, the company expects a half-year profit of around CHF 23 million (previous year: los...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .